On June 18, 2014, ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) sent a letter to Institutional Shareholder Services (“ISS”) requesting that ISS reconsider its recommendation that the Company’s stockholders vote against the following proposals in the Company’s proxy statement for its 2014 annual meeting to be held on June 25, 2014. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened today at $6.59 and is currently trading at $6.55. The stock showed a positive weekly performance of 2.50%.
Credit Suisse restated their outperform rating on shares of Celgene Corporation (NASDAQ:CELG) in a research note issued to investors on Thursday. The firm currently has a $225.00 price target on the stock, up from their previous price target of $210.00. Celgene Corporation (NASDAQ:CELG) stock opened at $169.70, in current trading session and currently is at $168.26, by losing -0.03%. The 52 week range of $110.53 – $174.66. Company’s market capitalization is 67.37 billion.
Inovio Pharmaceuticals Inc. (NYSEMKT:INO) has expanded its existing license agreement with the University of Pennsylvania, adding exclusive worldwide rights to technology and intellectual property for novel synthetic therapies against cancer, infectious diseases and new immune activators. Inovio has an ongoing collaborative research agreement with the university to support fundamental research in the area of DNA-based vaccines and immunotherapies. All newly licensed products are in preclinical development. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) stock is currently trading at $9.10. The EPS of the stock is -1.38. Company’s market capitalization is 547.43 million.
Insmed Incorporated (NASDAQ:INSM) announced that Company management will participate at the JMP Securities Healthcare Conference taking place June 24-25, 2014 at The Westin Grand Central in New York City. Insmed Incorporated (NASDAQ:INSM) stock opened the session at $18.85, and now is at $18.44. The 52 week range of the Insmed Incorporated (NASDAQ:INSM) stock remained $9.00 – $22.29 and the day range was $18.27 – $18.86.
The 2014 annual meeting of the stockholders of the OXiGENE Inc. (NASDAQ:OXGN) was held on June 10, 2014 at the Company’s offices in South San Francisco, California. Of the 15,300,820 shares of the Company’s common stock entitled to vote at the meeting, 9,474,048 shares were represented at the meeting in person or by proxy, constituting a quorum. Each of the nominees for director were duly elected and the other proposal described below was approved. OXiGENE Inc. (NASDAQ:OXGN) stock opened today at $2.70 and is currently trading at $2.65. The stock showed a positive weekly performance of 5.08%.